Clover Health Investments Corp
NASDAQ:CLOV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.16
4.82
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Clover Health Investments Corp
Clover Health Investments Corp. embarked on a mission to transform the healthcare landscape with its innovative approach as a next-generation Medicare Advantage insurer. Born out of the need to reduce inefficiencies and enhance care, Clover Health uses its proprietary technology platform, the Clover Assistant, to arm physicians with data-driven insights that facilitate informed decision-making at the point of care. By integrating technology with healthcare delivery, Clover targets not only the evident administrative wastage but also addresses the structural challenges faced by patients and providers alike. This unique integration of digital tools with a traditional insurance model sets Clover apart in an industry ripe for disruption.
Revenue for Clover Health primarily comes from Medicare Advantage premiums, where it competes by offering cost-effective plans combined with improved service. The company augments its financial model through government reimbursements tied to patient outcomes and the quality of care. Central to this strategy is the effective use of data analytics to manage patient care, reduce medical costs, and improve customer satisfaction. This alignment of financial incentives—lowering costs while enhancing patient outcomes—fuels Clover’s growth narrative, positioning it as a key player in reshaping how Medicare Advantage operates at the intersection of technology and healthcare delivery.
Clover Health Investments Corp. embarked on a mission to transform the healthcare landscape with its innovative approach as a next-generation Medicare Advantage insurer. Born out of the need to reduce inefficiencies and enhance care, Clover Health uses its proprietary technology platform, the Clover Assistant, to arm physicians with data-driven insights that facilitate informed decision-making at the point of care. By integrating technology with healthcare delivery, Clover targets not only the evident administrative wastage but also addresses the structural challenges faced by patients and providers alike. This unique integration of digital tools with a traditional insurance model sets Clover apart in an industry ripe for disruption.
Revenue for Clover Health primarily comes from Medicare Advantage premiums, where it competes by offering cost-effective plans combined with improved service. The company augments its financial model through government reimbursements tied to patient outcomes and the quality of care. Central to this strategy is the effective use of data analytics to manage patient care, reduce medical costs, and improve customer satisfaction. This alignment of financial incentives—lowering costs while enhancing patient outcomes—fuels Clover’s growth narrative, positioning it as a key player in reshaping how Medicare Advantage operates at the intersection of technology and healthcare delivery.
Membership & Revenue: Clover grew Medicare Advantage membership by 35% and revenue by nearly 50% year-over-year, outpacing competitors who retreated from the market.
Profitability Pressure: The company missed its adjusted EBITDA and star ratings targets due to higher-than-expected new member growth and elevated utilization, which led to lower profitability for 2025.
Guidance Lowered: Clover lowered its 2025 adjusted EBITDA and net income guidance, reflecting margin pressure and utilization trends, but raised membership and revenue guidance.
2026 Outlook: Management remains confident in achieving meaningful profitability and positive GAAP net income in 2026, driven by maturing member cohorts and a favorable 4-star payment year.
Clover Assistant Strength: Technology platform continues to drive clinical quality, with returning members managed by Clover Assistant delivering strong contribution profit.
Cost Management: SG&A as a percentage of revenue improved substantially year-over-year, supporting operating leverage despite growth investments.